| Literature DB >> 22138703 |
Aimen K Farraj1, Mehdi S Hazari, Darrell W Winsett, Anthony Kulukulualani, Alex P Carll, Najwa Haykal-Coates, Christina M Lamb, Edwin Lappi, Dock Terrell, Wayne E Cascio, Daniel L Costa.
Abstract
BACKGROUND: Ozone (O₃) is a well-documented respiratory oxidant, but increasing epidemiological evidence points to extrapulmonary effects, including positive associations between ambient O₃ concentrations and cardiovascular morbidity and mortality.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22138703 PMCID: PMC3295357 DOI: 10.1289/ehp.1104244
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1HR (A), PR interval (B), QTc (C), and ST area (D) immediately before (baseline) and during (exposure) 4-hr exposure to 0.2 ppm or 0.8 ppm O3 or filtered air (mean ± SE, n = 6). *Significantly less than preexposure baseline values within corresponding group (p < 0.05). **Significantly greater than preexposure baseline values within corresponding group (p < 0.05).
Figure 2RR interval (A), SDNN (B), RMSSD (C), and HF HRV domain (D) immediately before (baseline) and during (exposure) 4-hr exposure to 0.2 ppm or 0.8 ppm O3 or filtered air (mean ± SE, n = 6). *Significantly greater than preexposure baseline values within corresponding group (p < 0.05).
Number of arrhythmias per hour immediately before and during the 4-hr exposure period (mean ± SE).
| Exposure | Arrhythmia | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APB | SAB | AVB | ||||||||||
| Baseline | Exposure | Baseline | Exposure | Baseline | Exposure | |||||||
| Air | 0.5 ± 0.8 | 0.2 ± 0.2 | 1 ± 1 | 0.1 ± 0.2 | 0 ± 0 | 0.2 ± 0.2 | ||||||
| 0.2 ppm O3 | 3.5 ± 3.5 | 1.1 ± 0.4 | 1 ± 1 | 0.2 ± 0.3 | 0 ± 0 | 0 ± 0 | ||||||
| 0.8 ppm O3 | 1.0 ± 1.0 | 23 ± 14* | 1 ± 1 | 327 ± 99* | 0 ± 0 | 14 ± 7* | ||||||
| *Significantly greater than corresponding preexposure
baseline value ( | ||||||||||||
Figure 3Pearson product-moment correlation analysis between SDNN and RR (A), PR interval (B), SAB (C), and ST area (D) during exposure to 0.8 ppm O3. Simple regression lines are superimposed on each figure. The Pearson product-moment correlation coefficient (r) is indicated for each relationship.
Figure 4Cumulative dose of infused aconitine necessary to trigger ventricular premature beats (VPB), ventricular tachycardia (VT), ventricular fibrillation (VF), and cardiac arrest (CA) in rats approximately 18 hr after a single exposure to 0.2 ppm or 0.8 ppm O3 or filtered air (mean ± SE, n = 5). *Significantly less than air control for corresponding arrhythmia (p < 0.05).